JP2010265276A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010265276A5 JP2010265276A5 JP2010142096A JP2010142096A JP2010265276A5 JP 2010265276 A5 JP2010265276 A5 JP 2010265276A5 JP 2010142096 A JP2010142096 A JP 2010142096A JP 2010142096 A JP2010142096 A JP 2010142096A JP 2010265276 A5 JP2010265276 A5 JP 2010265276A5
- Authority
- JP
- Japan
- Prior art keywords
- aryl
- sulfonyl halide
- bis
- compound
- substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 claims 10
- -1 nitroaryl compound Chemical class 0.000 claims 9
- 150000003461 sulfonyl halides Chemical class 0.000 claims 5
- 125000002490 anilino group Chemical class [H]N(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 claims 4
- 229910044991 metal oxide Inorganic materials 0.000 claims 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims 3
- TVFDJXOCXUVLDH-UHFFFAOYSA-N caesium atom Chemical class [Cs] TVFDJXOCXUVLDH-UHFFFAOYSA-N 0.000 claims 2
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 claims 2
- TXCDCPKCNAJMEE-UHFFFAOYSA-N dibenzofuran Chemical compound C1=CC=C2C3=CC=CC=C3OC2=C1 TXCDCPKCNAJMEE-UHFFFAOYSA-N 0.000 claims 2
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 claims 2
- 229910052736 halogen Inorganic materials 0.000 claims 2
- 239000003960 organic solvent Substances 0.000 claims 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 2
- 125000000714 pyrimidinyl group Chemical group 0.000 claims 2
- 125000003107 substituted aryl group Chemical group 0.000 claims 2
- PTTUMBGORBMNBN-UHFFFAOYSA-N 1,2,3-trifluoro-5-nitrobenzene Chemical compound [O-][N+](=O)C1=CC(F)=C(F)C(F)=C1 PTTUMBGORBMNBN-UHFFFAOYSA-N 0.000 claims 1
- 125000004514 1,2,4-thiadiazolyl group Chemical group 0.000 claims 1
- NBWITVOFJWJOEF-UHFFFAOYSA-N 4-(4-chlorophenoxy)-3,5-difluorobenzenesulfonyl chloride Chemical group FC1=CC(S(Cl)(=O)=O)=CC(F)=C1OC1=CC=C(Cl)C=C1 NBWITVOFJWJOEF-UHFFFAOYSA-N 0.000 claims 1
- WXNZTHHGJRFXKQ-UHFFFAOYSA-N 4-chlorophenol Chemical compound OC1=CC=C(Cl)C=C1 WXNZTHHGJRFXKQ-UHFFFAOYSA-N 0.000 claims 1
- 150000008378 aryl ethers Chemical class 0.000 claims 1
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 claims 1
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 claims 1
- 235000010290 biphenyl Nutrition 0.000 claims 1
- 239000004305 biphenyl Substances 0.000 claims 1
- 125000000609 carbazolyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3NC12)* 0.000 claims 1
- 239000012954 diazonium Substances 0.000 claims 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-O diazynium Chemical compound [NH+]#N IJGRMHOSHXDMSA-UHFFFAOYSA-O 0.000 claims 1
- 125000001153 fluoro group Chemical group F* 0.000 claims 1
- 125000002541 furyl group Chemical group 0.000 claims 1
- 150000004820 halides Chemical group 0.000 claims 1
- 125000005843 halogen group Chemical group 0.000 claims 1
- 150000002367 halogens Chemical class 0.000 claims 1
- 125000001072 heteroaryl group Chemical group 0.000 claims 1
- 125000002883 imidazolyl group Chemical group 0.000 claims 1
- 125000001041 indolyl group Chemical group 0.000 claims 1
- 239000013067 intermediate product Substances 0.000 claims 1
- 125000005956 isoquinolyl group Chemical group 0.000 claims 1
- 125000001786 isothiazolyl group Chemical group 0.000 claims 1
- 125000000842 isoxazolyl group Chemical group 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 125000001624 naphthyl group Chemical group 0.000 claims 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 1
- 125000004999 nitroaryl group Chemical group 0.000 claims 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 claims 1
- 125000000561 purinyl group Chemical group N1=C(N=C2N=CNC2=C1)* 0.000 claims 1
- 125000003373 pyrazinyl group Chemical group 0.000 claims 1
- 125000003226 pyrazolyl group Chemical group 0.000 claims 1
- 125000001725 pyrenyl group Chemical group 0.000 claims 1
- 125000004076 pyridyl group Chemical group 0.000 claims 1
- 125000005493 quinolyl group Chemical group 0.000 claims 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 claims 1
- CXWXQJXEFPUFDZ-UHFFFAOYSA-N tetralin Chemical compound C1=CC=C2CCCCC2=C1 CXWXQJXEFPUFDZ-UHFFFAOYSA-N 0.000 claims 1
- 125000003831 tetrazolyl group Chemical group 0.000 claims 1
- 125000001544 thienyl group Chemical group 0.000 claims 1
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US38832602P | 2002-06-12 | 2002-06-12 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004513217A Division JP4718172B2 (ja) | 2002-06-12 | 2003-06-11 | ヒトａｄａｍ−１０インヒビター |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010265276A JP2010265276A (ja) | 2010-11-25 |
| JP2010265276A5 true JP2010265276A5 (enExample) | 2011-08-18 |
Family
ID=29736461
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004513217A Expired - Fee Related JP4718172B2 (ja) | 2002-06-12 | 2003-06-11 | ヒトａｄａｍ−１０インヒビター |
| JP2010142096A Pending JP2010265276A (ja) | 2002-06-12 | 2010-06-22 | ヒトａｄａｍ−１０インヒビター |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004513217A Expired - Fee Related JP4718172B2 (ja) | 2002-06-12 | 2003-06-11 | ヒトａｄａｍ−１０インヒビター |
Country Status (7)
| Country | Link |
|---|---|
| US (5) | US7629341B2 (enExample) |
| EP (3) | EP2436676A1 (enExample) |
| JP (2) | JP4718172B2 (enExample) |
| AU (2) | AU2003237532B2 (enExample) |
| CA (1) | CA2485346C (enExample) |
| ES (1) | ES2425013T3 (enExample) |
| WO (1) | WO2003106381A2 (enExample) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7517884B2 (en) * | 1998-03-30 | 2009-04-14 | Kalypsys Inc. | Sulfonyl-substituted bicyclic compounds as modulators of PPAR |
| AU2003237532B2 (en) | 2002-06-12 | 2009-07-30 | Symphony Evolution, Inc. | Human ADAM-10 inhibitors |
| ES2537514T3 (es) | 2003-04-04 | 2015-06-09 | Incyte Corporation | Composiciones, métodos y kits relacionados con la escisión de HER-2 |
| EP1623995A1 (en) * | 2004-08-06 | 2006-02-08 | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts | Inhibitors of L1 and ADAM10 for the treatment of carcinomas |
| US20070190079A1 (en) * | 2004-10-29 | 2007-08-16 | Kalypsys, Inc. | Methods for the selective modulation of ppar |
| KR101404930B1 (ko) | 2004-10-29 | 2014-06-09 | 칼립시스, 인코포레이티드 | Ｐｐａｒ의 조절자로서 술포닐-치환된 바이시클릭 화합물 |
| WO2006110583A2 (en) * | 2005-04-07 | 2006-10-19 | Novartis Vaccines And Diagnostics Inc. | Adam10 in cancer diagnosis, detection and treatment |
| AU2006305769B2 (en) * | 2005-10-25 | 2012-06-14 | Kalypsys, Inc. | Salts of modulators of PPAR and methods of treating metabolic disorders |
| WO2007084488A2 (en) | 2006-01-13 | 2007-07-26 | Vanderbilt University | Adam10 and its uses related to infection |
| CN100506804C (zh) * | 2006-01-26 | 2009-07-01 | 于学敏 | 羟苯磺酸烷基吡嗪药物及其制备方法和应用 |
| US20070249519A1 (en) * | 2006-04-20 | 2007-10-25 | Kalypsys, Inc. | Methods for the upregulation of glut4 via modulation of ppar delta in adipose tissue and for the treatment of disease |
| AR060937A1 (es) * | 2006-05-16 | 2008-07-23 | Kalypsys Inc | Compuestos biciclicos sustituidos con sulfonilo como moduladores de ppar |
| US20080176861A1 (en) | 2007-01-23 | 2008-07-24 | Kalypsys, Inc. | Sulfonyl-substituted bicyclic compounds as ppar modulators for the treatment of non-alcoholic steatohepatitis |
| WO2009052200A2 (en) * | 2007-10-16 | 2009-04-23 | Symphony Evolution, Inc. | Human adam-10 inhibitors |
| EP3173415B1 (en) * | 2008-10-09 | 2019-06-05 | The U.S.A. as represented by the Secretary, Department of Health and Human Services | Activators of human pyruvate kinase |
| CN102639134A (zh) * | 2009-10-01 | 2012-08-15 | 和谐进化股份有限公司 | 使用基质金属蛋白酶-2抑制剂治疗动脉瘤样扩张、血管壁薄弱、特别是腹主动脉瘤和胸主动脉瘤的方法 |
| US20130109672A1 (en) | 2010-04-29 | 2013-05-02 | The United States Of America,As Represented By The Secretary, Department Of Health And Human Service | Activators of human pyruvate kinase |
| JP5888667B2 (ja) * | 2010-04-30 | 2016-03-22 | 国立大学法人名古屋大学 | Ａｄａｍ作用阻害物質のスクリーニング方法、仮足の保持方法、仮足保持剤、仮足の制御物質のスクリーニング方法、及びａｄａｍ作用阻害剤 |
| EP2637679A4 (en) | 2010-11-09 | 2015-09-23 | Univ Chicago | ROLE OF ADAM10 AND ITS RELEVANCE TO DISEASES AND THERAPEUTICS |
| WO2014028334A1 (en) * | 2012-08-11 | 2014-02-20 | Symphony Evolution, Inc. | Selective mmp inhibitors |
| WO2015112842A1 (en) * | 2014-01-24 | 2015-07-30 | Ntercept, Llc | Methods and compositions for immune dis-inhibition |
| MY203626A (en) | 2014-10-03 | 2024-07-10 | Nanotics Llc | Compositions and methods for inhibiting the biological activity of soluble biomolecules |
| HK1255329A1 (zh) | 2015-07-29 | 2019-08-16 | 纳米提克斯有限责任公司 | 用於清除可溶性生物分子的模块化组合物及其相关方法 |
| WO2018129207A1 (en) | 2017-01-04 | 2018-07-12 | Nanotics, Llc | Methods for assembling scavenging particles |
| CN108947850B (zh) * | 2018-07-23 | 2021-05-18 | 蚌埠中实化学技术有限公司 | 一种3,4,5-三氟苯胺的制备方法 |
| KR20220023988A (ko) | 2019-05-14 | 2022-03-03 | 웨어울프 세라퓨틱스, 인크. | 분리 모이어티 및 이의 사용 방법 |
| EP4058471A1 (en) | 2019-11-14 | 2022-09-21 | Werewolf Therapeutics, Inc. | Activatable cytokine polypeptides and methods of use thereof |
| CN113563235B (zh) * | 2021-07-28 | 2023-04-11 | 上海毕得医药科技股份有限公司 | 一种3-(卤代苯氧基)苯磺酰氯衍生物的合成方法 |
| WO2023172594A2 (en) * | 2022-03-08 | 2023-09-14 | Nova Southeastern University | Method for treating rheumatoid arthritis (ra) using an enzyme-and substrate selective exosite inhibitor of a disintegrin and metalloprotease 10 (adam10) |
Family Cites Families (51)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1016245A (en) * | 1962-11-06 | 1966-01-05 | Ici Ltd | Manufacture of polysulphones |
| US4213775A (en) * | 1977-07-28 | 1980-07-22 | Ube Industries, Ltd. | Diphenyl ether derivatives and herbicidal compositions containing the same |
| DE3107700A1 (de) * | 1981-02-28 | 1982-09-16 | Basf Ag, 6700 Ludwigshafen | Verfahren zur herstellung von aromatischen sulfohalogeniden |
| JP3040161B2 (ja) | 1990-03-01 | 2000-05-08 | ファルマシア・アンド・アップジョン・カンパニー | 急性乳酸アシドーシスを予防するためのルーメン内細菌 |
| DE4015834A1 (de) * | 1990-05-17 | 1991-11-21 | Bayer Ag | Phenoxyphenylsulfonylverbindungen |
| US5215549A (en) | 1991-05-08 | 1993-06-01 | Mobil Oil Corporation | Thioester derived hindered phenols and aryl-amines as antioxidant and antiwear additives |
| DE4327026A1 (de) | 1993-08-12 | 1995-02-16 | Bayer Ag | Arylsulfonyloxyphosphonsäurederivate |
| DE69519751T2 (de) | 1995-04-20 | 2001-04-19 | Pfizer Inc., New York | Arylsulfonamido-substituierte hydroxamsäure derivate als inhibitoren von mmp und tnf |
| JP3837761B2 (ja) * | 1995-08-04 | 2006-10-25 | 住友精化株式会社 | ハロベンゼンスルホニルクロリド類の製造方法 |
| DE19537334A1 (de) | 1995-10-09 | 1997-04-10 | Hoechst Ag | Antiadhäsive Piperidin- und Pyrrolidin-Carbonsäuren |
| US5753653A (en) * | 1995-12-08 | 1998-05-19 | Agouron Pharmaceuticals, Inc. | Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses |
| US6500948B1 (en) | 1995-12-08 | 2002-12-31 | Agouron Pharmaceuticals, Inc. | Metalloproteinase inhibitors-compositions, uses preparation and intermediates thereof |
| IL124559A (en) | 1995-12-08 | 2004-07-25 | Agouron Pharma | Inhibitors of metalloproteinases, pharmaceutical preparations containing them and their use |
| IL128662A0 (en) | 1996-08-28 | 2000-01-31 | Procter & Gamble | Heterocyclic metalloprotease inhibitors |
| EP0963432A4 (en) | 1996-08-29 | 2002-11-20 | Univ California | KUZ, NEW FAMILY OF METALLOPROTEASES |
| US6333324B1 (en) | 1996-12-17 | 2001-12-25 | Fujisawa Pharmaceutical Co., Ltd. | Piperazine compounds as inhibitors of MMP or TNF |
| DK0958287T3 (da) * | 1997-01-23 | 2003-01-20 | Hoffmann La Roche | Sulfamidmetalloprotease-inhibitorer |
| NZ336836A (en) | 1997-02-11 | 2001-02-23 | Pfizer | Arylsulfonyl hydroxamic acid derivatives suitable for a broad range of medicinal treatments |
| WO1998043963A1 (en) * | 1997-04-01 | 1998-10-08 | Agouron Pharmaceuticals, Inc. | Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses |
| US5922546A (en) | 1997-08-25 | 1999-07-13 | Smithkline Beecham Corporation | Human disintegrin metalloprotease KUZ gene |
| JP4327915B2 (ja) * | 1998-03-30 | 2009-09-09 | 株式会社デ・ウエスタン・セラピテクス研究所 | スルフォンアミド誘導体 |
| GT199900044A (es) * | 1998-04-10 | 2000-09-14 | Procedimientos para preparar haluros de fenoxifenilsulfonilo. | |
| CN1301265A (zh) | 1998-05-14 | 2001-06-27 | 杜邦药品公司 | 新的用作金属蛋白酶抑制剂的取代的芳基异羟肟酸 |
| JP3623448B2 (ja) | 1998-08-12 | 2005-02-23 | ファイザー・プロダクツ・インク | Ｔａｃｅインヒビター |
| US6509337B1 (en) | 1998-09-17 | 2003-01-21 | Pfizer Inc. | Arylsulfonyl Hydroxamic Acid derivatives as MMP and TNF inhibitors |
| AR035313A1 (es) | 1999-01-27 | 2004-05-12 | Wyeth Corp | Inhibidores de tace acetilenicos de acido hidroxamico de sulfonamida a base de alfa-aminoacidos, composiciones farmaceuticas y el uso de los mismos para la manufactura de medicamentos. |
| US6225311B1 (en) | 1999-01-27 | 2001-05-01 | American Cyanamid Company | Acetylenic α-amino acid-based sulfonamide hydroxamic acid tace inhibitors |
| JP2000247975A (ja) | 1999-02-25 | 2000-09-12 | Nissan Chem Ind Ltd | ヘテロ環縮合ピリミジノン誘導体及びそれらを含む除草剤 |
| US6387901B1 (en) | 1999-07-06 | 2002-05-14 | Pfizer Inc | Alkyne containing metalloproteinase inhibitors |
| EP1081137A1 (en) | 1999-08-12 | 2001-03-07 | Pfizer Products Inc. | Selective inhibitors of aggrecanase in osteoarthritis treatment |
| WO2001055112A1 (en) * | 2000-01-27 | 2001-08-02 | American Cyanamid Company | Method for preparing alpha-sulfonyl hydroxamic acid derivatives |
| US6664291B2 (en) * | 2000-03-31 | 2003-12-16 | Pfizer, Inc. | Malonamic acids and derivatives thereof as thyroid receptor ligands |
| JP4635162B2 (ja) * | 2000-04-27 | 2011-02-16 | 独立行政法人理化学研究所 | 芳香族ジアミンの製造方法及び芳香族ジアミン化合物 |
| AU2002255613A1 (en) | 2001-02-27 | 2002-09-12 | Axys Pharmaceuticals, Inc. | Piperazine derivatives as metalloprotease inhibitors |
| CA2357110A1 (en) | 2001-04-11 | 2002-10-11 | American Cyanamid Company | Method for the treatment of polycystic kidney disease |
| WO2002088115A1 (en) | 2001-04-26 | 2002-11-07 | Kolon Ind. Inc. | Novel sulfonamide derivatives, intermediate thereof, its preparation methods, and pharmaceutical composition comprising the same |
| US6399823B1 (en) * | 2001-04-30 | 2002-06-04 | General Electric Company | Method for producing phosgene |
| MXPA04004010A (es) | 2001-11-01 | 2004-07-23 | Wyeth Corp | Acidos hidroxamicos de aril sulfonamida alenicos como inhibidores de tace y metaloproteinasa de matriz. |
| CN1173960C (zh) | 2001-12-06 | 2004-11-03 | 中国人民解放军军事医学科学院毒物药物研究所 | 取代六元氮杂环类化合物及其作为神经调节剂的用途 |
| EP1461313B1 (en) * | 2001-12-14 | 2009-08-05 | Exelixis, Inc. | Human adam-10 inhibitors |
| AU2002361096A1 (en) | 2001-12-27 | 2003-07-15 | Sumitomo Pharmaceuticals Company, Limited | Hydroxamic acid derivative and mmp inhibitor containing the same as active ingredient |
| US7189856B2 (en) | 2001-12-28 | 2007-03-13 | Gideon Shapiro | Non-peptide somatostatin receptor ligands |
| US7488754B2 (en) | 2002-04-05 | 2009-02-10 | Wyeth | Method for the treatment of polycystic kidney disease |
| AU2003237532B2 (en) | 2002-06-12 | 2009-07-30 | Symphony Evolution, Inc. | Human ADAM-10 inhibitors |
| MXPA05001603A (es) | 2002-08-13 | 2005-04-25 | Warner Lambert Co | Derivados monociclicos como inhibidores de metaloproteinasa de matriz. |
| EP1400244A1 (en) | 2002-09-17 | 2004-03-24 | Warner-Lambert Company LLC | New spirocondensed quinazolinones and their use as phosphodiesterase inhibitors |
| JP4825664B2 (ja) | 2003-02-14 | 2011-11-30 | メルク セローノ ソシエテ アノニム | ピペラジン−２−カルボキサミド誘導体 |
| BRPI0407587A (pt) | 2003-02-18 | 2006-02-14 | Pfizer | inibidores do vìrus da hepatite c, composições e tratamentos que os utilizam |
| US7563781B2 (en) | 2005-01-14 | 2009-07-21 | Janssen Pharmaceutica Nv | Triazolopyrimidine derivatives |
| US20070155730A1 (en) | 2005-08-26 | 2007-07-05 | Methylgene, Inc. | Benzodiazepine And Benzopiperazine Analog Inhibitors Of Histone Deacetylase |
| EP1937632A1 (en) | 2005-10-06 | 2008-07-02 | Astra Zeneca AB | Novel compounds |
-
2003
- 2003-06-11 AU AU2003237532A patent/AU2003237532B2/en not_active Ceased
- 2003-06-11 JP JP2004513217A patent/JP4718172B2/ja not_active Expired - Fee Related
- 2003-06-11 EP EP11188699A patent/EP2436676A1/en not_active Withdrawn
- 2003-06-11 ES ES03736979T patent/ES2425013T3/es not_active Expired - Lifetime
- 2003-06-11 CA CA2485346A patent/CA2485346C/en not_active Expired - Fee Related
- 2003-06-11 EP EP03736979.0A patent/EP1511488B1/en not_active Expired - Lifetime
- 2003-06-11 US US10/518,110 patent/US7629341B2/en not_active Expired - Fee Related
- 2003-06-11 WO PCT/US2003/018262 patent/WO2003106381A2/en not_active Ceased
- 2003-06-11 EP EP11188701A patent/EP2428509A1/en not_active Withdrawn
-
2009
- 2009-10-23 US US12/605,118 patent/US7989661B2/en not_active Expired - Fee Related
- 2009-10-28 AU AU2009230801A patent/AU2009230801A1/en not_active Abandoned
-
2010
- 2010-06-22 JP JP2010142096A patent/JP2010265276A/ja active Pending
-
2011
- 2011-06-23 US US13/167,128 patent/US20120071653A1/en not_active Abandoned
-
2012
- 2012-07-03 US US13/541,503 patent/US20130144056A1/en not_active Abandoned
-
2014
- 2014-03-21 US US14/221,937 patent/US20140206865A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010265276A5 (enExample) | ||
| Barata‐Vallejo et al. | Recent advances in trifluoromethylation reactions with electrophilic trifluoromethylating reagents | |
| Zhao et al. | A class of amide ligands enable Cu-catalyzed coupling of (hetero) aryl halides with sulfinic acid salts under mild conditions | |
| Kang et al. | Copper-catalyzed trifluoromethylthiolation of aryl and vinyl boronic acids with a shelf-stable electrophilic trifluoromethylthiolating reagent | |
| Egami et al. | Alkene Trifluoromethylation Coupled with C C Bond Formation: Construction of Trifluoromethylated Carbocycles and Heterocycles. | |
| Singh et al. | Aerobic oxysulfonylation of alkynes in aqueous media: highly selective access to β-keto sulfones | |
| RU2017102355A (ru) | Способ получения конденсированного гетероциклического соединения | |
| JP2008523069A5 (enExample) | ||
| JP2009263394A5 (enExample) | ||
| JP2016153424A5 (enExample) | ||
| JP2014512451A5 (enExample) | ||
| JP2014508811A5 (enExample) | ||
| JP2013063963A5 (ja) | 複素環化合物 | |
| JP2012521377A5 (enExample) | ||
| JP2013529602A5 (enExample) | ||
| RU2016135762A (ru) | Способ получения (r)-1,1,3-триметил-4-аминоиндана | |
| JP2017533203A5 (enExample) | ||
| Wan et al. | Chemo‐selective copper‐catalyzed C‐O coupling reactions of phenols with aryl/vinyl halides using enaminone as efficient ligand | |
| JP2010522214A5 (enExample) | ||
| JP2012508747A5 (enExample) | ||
| Talukdar et al. | Ullmann-Type N-, S-, and O-Arylation Using a Well-Defined 7-Azaindole-N-oxide (7-AINO)-Based Copper (II) Catalyst: Scope and Application to Drug Synthesis | |
| CN105198841B (zh) | 一种药物中间体多取代呋喃类化合物的合成方法 | |
| Feng et al. | Copper-catalyzed conversion of aryl and heteroaryl bromides into the corresponding chlorides | |
| CN102603735B (zh) | 一种c-2芳基化吲哚嗪化合物的制备方法 | |
| JP2018515468A5 (enExample) |